Canopy Growth Corp. Archives - Green Market Report

Adam JacksonNovember 9, 2022
Canopy-Growth_feature-scaled.jpg?fit=1200%2C568&ssl=1

7min5740

Shares of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) were popping by over 9% in early Wednesday trading as the company posted results that show rising demand for its non-cannabis ventures, despite burdening debt and uncertainty around its consolidation plans. The stock was lately selling at $3.50. The company released its financial results for the second quarter ending September 30 with net revenue of C$118 million in the second quarter, down 12% versus C$135 million last year, but still a 7% improvement versus the previous quarter’s $110 million.

Total revenue earnings were not immediately available and could not be compared to Yahoo Finance’s average analysts’ estimate of C$83.7 million as of press time, though the posted net revenue is still higher than estimates.

Net loss widened to C$232 million, up C$200 million (625%) versus last year’s C$32 million, though down considerably from the previous quarter’s C$2 billion cash burn. The company said that net loss could be attributed to non-cash fair value changes and an increase in asset impairment and restructuring costs, with improved margins in the mix providing some cushion.

“We delivered solid sequential quarterly net revenue growth and improved margins, led by another record quarter for BioSteel, the stabilization of our Canadian cannabis business, and continued actions to reduce overall costs,” said CFO Judy Hong. “We are pressing forward on our path to profitability in Canada and expect Canopy USA will meaningfully enhance our growth and profitability over time once it closes the announced acquisitions of Acreage, Jetty, and Wana.”

Cash Burn

Canopy noted that the free cash flow in the fiscal second quarter was an outflow of C$135 million, a 34% increase in outflow versus last year’s second quarter. Canopy attributed this to the timing of certain payments in each period. The company said that the year-to-date free cash flow is in line with the prior year period. Investors can remain calm for now as the cash and short-term investments amounted to $1.1 billion on September 30, 2022. However, this does represent a decrease of $229 million from $1,372 million on March 31, 2022, reflecting primarily Adjusted EBITDA losses and interest costs.

BioSteel Boost

The company’s majority stake in hydration drink BioSteel proved to be fruitful, as revenue in the quarter rose 299% versus last year. BioSteel has secured distribution with large retailers and inked a multi-year partnership in July with the National Hockey League and the National Hockey League Players Association as an “official hydration partner.”

Under the accord, BioSteel is given league-wide rink-side marketing and product supply rights, retail activation rights as well as a community engagement platform.

Canopy said that it acquired a manufacturing facility on Tuesday, “which is expected to support ongoing rapid U.S. expansion for the brand and drive gross margin improvement.”

At the same time, the company also announced that it would divest from its vertical retail operations and sell off all of its stores, focusing on the core consumer packaged goods business instead.

Canopy also made headlines on the news that it would trigger hibernating deals to buy three U.S. plant-touching companies under separate holdings umbrella, though the plans face complications that could affect its listing status on the Nasdaq.

Stifel analyst Andrew Carter downgraded the company to a “Sell” rating after the announcement, citing Canopy’s debt versus the company’s valuations on its businesses.

“We weigh C$1.4 million of value against C$240 million of net debt as well as the $750 million term debt’s remaining interest expense included in the make-whole provision,” he wrote in the report.

Canopy reported a gross margin of 3% versus 54% in the same quarter last year.

Adjusted EBITDA loss was $78 million, an $85 million improvement versus the same time last year, due to the improvement in gross margin and reductions in G&A and R&D expenses.

“Our second quarter marks a key inflection-point for Canopy, demonstrating momentum across our key businesses and accelerating our entry into the U.S. cannabis market through the creation of Canopy USA,” said CEO David Klein. Canopy is ideally positioned to capitalize on this once-in-a-generation opportunity and accelerate our path to North American cannabis market leadership.”


StaffOctober 25, 2022
daily_hit001.png?fit=1200%2C344&ssl=1

5min10040

The Daily Hit is a recap of cannabis business news for Oct. 25, 2022.

ON THE SITE

Canopy Growth Forms New Holding Company to Speed US Entry

Canadian cannabis producer Canopy Growth Corp. (TSX: WEED) (NASDAQ: CGC) has agreed to absorb a trio of companies within its newly formed holdings entity, Canopy USA. Under the deals, which still need approvals from shareholders, Canopy USA will acquire all of Acreage Holdings (OTC: ACRHF), as well as Jetty Extracts and Wana Brands, in a longstanding bid to gain entry into the U.S. cannabis industry. Read more here.

SEC Charges Cronos Group With Accounting Fraud

The Securities and Exchange Commission (SEC) charged Cronos Group Inc. (Nasdaq: CRON)  for improperly accounting for millions of dollars of revenue and for other accounting misconduct in multiple reporting periods. The SEC said in a statement that it also charged Cronos’s former Chief Commercial Officer, William Hilson, with fraud and aiding and abetting the company’s violations. Read more here.

CBD Beverage Company Targeted by SEC For False Statements

The SEC is issuing cease-and-desist orders against a CBD beverage company called NewAge Inc. The SEC said in its Administrative Proceeding dated Oct. 19, 2022 that from approximately July 2017 through April 2019, NewAge, through its former chief executive officer and director Brent D. Willis, made numerous false and misleading public statements concerning NewAge’s business operations and activities. Read more here.

Michigan’s Top Cannabis Regulator Promises Crackdown as Prices Free-Fall

For Michigan’s marijuana industry, a crackdown is coming. The state’s Cannabis Regulatory Agency is preparing to launch a new offensive to combat illicit market product that’s been long-rumored to be making its way into the regulated industry, Brian Hanna, the newly appointed acting director of the agency, told reporters in a media roundtable Tuesday morning at the CRA’s Lansing headquarters. Read more here.

IN OTHER NEWS

New York

Leaders of NY’s largest cannabis business association say certain aspects of the state’s marijuana testing regulations are unnecessarily strict and that if they’re not changed, most of NY’s conditionally licensed growers won’t be able to sell their weed. The Office of Cannabis Management last month posted testing requirements for marijuana flower and extract. Read more here.

Goodness Growth/Verano Holdings

Cannabis company Goodness Growth saw its market cap drop by more than 60% after Verano Holdings backed out of a deal to buy the Canadian firm for $413 million, according to a lawsuit filed Friday in the Supreme Court of British Columbia accusing the Chicago-based company of “undermining” the deal. Read more here.


Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 9 hours

FDA Says CBD Still Can’t Be Dietary Supplement

@GreenMarketRpt – 13 hours

Mind Cure Continues Its Winding Down Process

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.